Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AbbVie’s Maviret receives Japanese MHLW approval to treat HCV

pharmaceufical-technologySeptember 29, 2017

Tag: AbbVie , MHLW , HCV

PharmaSources Customer Service